Management of allergic bronchopulmonary aspergillosis

The management of allergic bronchopulmonary aspergillosis (ABPA) is similar regardless of the cause. Treatment requires specialist advice; it can include systemic corticosteroid and antifungal therapy.

In patients with cystic fibrosis (CF), pharmacokinetic monitoring by a specialist centre is required because the pharmacokinetics of antifungal drugs in patients with CF are complex.